Skip to content

Clinical trials

Terminated Phase 2 Dyslipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 2 Status: Terminated Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20081
20111
20132
20161
20171
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda3
Gloria Vega1
Hospital Nacional Homeopático, Mexico1
Merck Sharp & Dohme LLC1
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Pronova BioPharma1
Resverlogix Corp1
Solvay Pharmaceuticals1
University of Iowa1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias11
Obesity3
Diabetes Mellitus2
Diabetes Mellitus, Lipoatrophic2
Diabetes Mellitus, Type 22
Glucose Metabolism Disorders2
Coronary Artery Disease1
Glucose Intolerance1
HIV Infections1
Hypercholesterolemia1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.